Pfe stock forecast 2025.

Abbott Laboratories Stock Forecast, ABT stock price prediction. Price target in 14 days: 110.070 USD. ... Abbott Laboratories Stock Price Forecast for 2025: February ...Target values for the price of one Pfizer share for Dec 2023. The weighted average target price per Pfizer share in Dec 2023 is: 32.81. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 8.084% volatility is expected. Pessimistic target level: 31.89. Optimistic target level: 34.70.Forecast: (PFE) for 2023-2027 All stock predictions Overall outlook for Pfizer stock Tomorrow Week Month 2023 2024 2025 2026 2027 PFE dividends TOP …Apr 20, 2023 · Pfizer recently predicted that all of the upcoming losses of exclusivity will result in $17 billion of lost revenue between 2025 and 2030. So the next few years may be bumpy for the company. 3 ...

Viatris Inc Stock Forecast 2023. In the last five quarters, Viatris Inc’s Price Target has fallen from $14.62 to $11.74 - a -19.7% decrease. Eight analysts predict that Viatris Inc’s share price will fall in the coming year, reaching $11.50. This would represent a decrease of -2.04%.

2 thg 5, 2023 ... The company reaffirmed its forecast of $13.5 billion in Covid vaccine sales in 2023 and $8 billion in revenue for Paxlovid. Pfizer CEO Albert ...Jan 12, 2023 · The consensus outlook for Pfizer has full-year earnings in 2023 coming in 25% below the level for 2022, with further declines in 2024 and 2025 according to ETrade. The consensus expected EPS ...

Dec 13, 2022 · At Pipeline Day, Pfizer Inc (NYSE: PFE) forecasts annual revenue from its mRNA vaccine portfolio could reach $10-$15 billion by 2030. Last month in its Q3 earnings release, Pfizer raised its ... PEP Stock 12 Months Forecast. $189.67. (12.82% Upside) Based on 19 Wall Street analysts offering 12 month price targets for PepsiCo in the last 3 months. The average price target is $189.67 with a high forecast of $210.00 and a low forecast of $172.00. The average price target represents a 12.82% change from the last price of $168.11.Moderna Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030. Moderna Inc's EPS has increased by 1398.06% In the last three years, going from $-1.55 to $20.12. According to 17 major analysts, Moderna Inc's EPS will fall by 163.62% in the next year, reaching $-12.80. For the next eight years, the forecast is for EPS to grow by 48.11%.Target values for the price of one Paysafe share for Jun 2025. The weighted average target price per Paysafe share in Jun 2025 is: 15.29. In Jun, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 8.917% volatility is expected. Pessimistic target level: 14.50. Optimistic target level: 15.92.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com

Tesla Free Cash Flow Forecast for 2023 - 2025 - 2030. In the last three years, Tesla's Free Cash Flow has seen an increase, rising from $973.00M to $8.24B. This represents a growth of 747.07%. According to the 19 analysts polled, in the next year, Tesla's Free Cash Flow will fall by 20.72%, reaching $6.53B. Over the next eight years, experts ...

Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $52.14 target price for Citigroup stock stock. Today 200 Day Moving Average is the resistance level (46.25 $). 50 Day Moving Average is the resistance level (41.8 $). 2023.

Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $187.28B. -23.7%. Market Cap / …Oct 16, 2023 · Pfizer stock falls after company slashes $9 billion from sales outlook ... PFE-5.12%. BNTX-1.01%. SPX ... Pfizer forecast in August full-year earnings of $3.25 to $3.45 a share on revenue of $67 ... Find real-time AZN - AstraZeneca PLC stock quotes, company profile, news and forecasts from CNN Business.Wall Street Stock Market & Finance report, prediction for the future: You'll find the PENN Entertainment share forecasts, stock quote and buy / sell signals below. According to present data PENN Entertainment's PENN shares and potentially its market environment have been in bearish cycle last 12 months (if exists).The Pfizer stock prediction for 2025 is currently $ 36.25, assuming that Pfizer shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 15.95% increase in the PFE stock price. In 2025, PFE is forecast to generate $19,480,125,857 in earnings, with the lowest earnings forecast at $17,390,952,939 and the highest earnings forecast at $22,924,437,966. ... Wall Street analysts that have issued a 1 year PFE price target, the average PFE price target is $40.67, with the highest PFE stock price forecast at $75.00 and the ...Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for Solid Power stock is $3.58, which predicts an increase of 140.27%. The lowest target is $2.00 and the highest is $5.00. On average, analysts rate Solid Power stock as a buy.

What Will Pfizer Stock Be Worth in 2025-2030. The average Pfizer stock forecast 2025 represents a 6587 increase from the last price of 485299987792969. Pfizer Huge Share Float Flattens Pfe Stock S Growth Prospects Seeking Alpha There were 10 buy ratings and nine hold recommendations with no sell ratings.Price Prediction forecast forPfizer to October 12, and an in-depth analysis for the week of 8 October to 14 October. Monthly forecasts PFE for 2023 with target levels, support & resistance insights to make informed investment decisions.From AI system, total return is 2366.52% from 4098 forecasts. For Lloyds Banking Group plc stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Lloyds Banking Group plc stock forecast of 30.77, a high forecast of 42.54, and a low forecast of 19.99. The average Lloyds Banking Group plc stock …Oct 30, 2023 · Pfizer Stock Forecast 11-23-2023. Forecast target price for 11-23-2023: $ 30.86. Positive dynamics for Pfizer shares will prevail with possible volatility of 2.980%. Pessimistic target level: 30.59. Optimistic target level: 31.53. Jun 29, 2023 · Credit Suisse downgrades Pfizer, says pharma giant will struggle to keep up with competitors. Published Thu, Jun 29 20237:06 AM EDT Updated Thu, Jun 29 202311:59 AM EDT. Alex Harring @alex_harring.

The latest Pfizer stock prices, stock quotes, news, and PFE history to help you invest and trade smarter. ... The 64 analysts offering price forecasts for Pfizer have a median target of 51.39 ...

Pfizer stock forecast for 01-2025. Uptrend forecast for this month with an optimal price target of $52.131. Pessimistic: $52.028. Optimistic: $52.308. Pfizer stock forecast for 02-2025. Uptrend forecast for this month with an optimal price target of $51.988. Pessimistic: $51.811. Optimistic: $52.104. Pfizer stock forecast for 03-2025.Pfizer Stock Forecast 12-04-2023. ... Forecast target price for 12-04-2023: $29.82. Negative dynamics for Pfizer shares will prevail with possible volatility of ...Dec 9, 2022 · The performance of Pfizer can be bullish in 2025 but it will hardly touch the recent ATH. By 2025, we may expect an average price of $78.53 for Pfizer stock. If current growth continues, our maximum forecast for Pfizer is $85.75 in 2025. The minimum price level of Pfizer can be around $71.86 if the market turns bearish. In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Pfizer and its promising trajectory, we have meticulously collated insights from various analyst forecasts. Our consensus forecast for 2023 is a composite reflection of diverse expert analyses, ensuring a balanced and informed …Dec 9, 2022 · The performance of Pfizer can be bullish in 2025 but it will hardly touch the recent ATH. By 2025, we may expect an average price of $78.53 for Pfizer stock. If current growth continues, our maximum forecast for Pfizer is $85.75 in 2025. The minimum price level of Pfizer can be around $71.86 if the market turns bearish. Aug 9, 2021 · Pfizer (PFE-5.12%) has been an underachiever. Sure, the company launched a successful COVID-19 vaccine and has built a large pipeline. However, its shares have lagged well behind the market for years. Pfizer Inc. analyst ratings, historical stock prices, earnings estimates & actuals. PFE updated stock price target summary. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Broa share forecasts, stock quote and buy / sell signals below. According to present data Broa's AVGO shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).PepsiCo Inc EBITDA Forecast for 2023 - 2025 - 2030. In the last three years, PepsiCo Inc's EBITDA has grown by 14.69%, rising from $12.99B to $14.89B. For the next year, analysts predict that EBITDA will reach $16.23B – an increase of 9.01%. Over the next eight years, experts believe that PepsiCo Inc's EBITDA will grow at a rate of 66.92%.

2.74%. $30.13B. PFE | Complete Pfizer Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Ocugen Stock Forecast 2023, 2024, 2025. Pfizer stock price predictions for March 2024. The forecast for beginning of March 27.15. Maximum value 28.92, while …

The Broa stock forecast is 1436.1958280343 USD for 2024 November 30, Saturday; and 4322.190 USD for 2028 November 30, Thursday with technical analysis. Broa (AVGO) stock price prediction is 1436.1958280343 USD.Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $44.38 target price for Pfizer stock stock. Today 200 Day Moving Average is the resistance level (40.35 $). 50 Day Moving Average is the resistance level (35.47 $). 2023.Price Prediction Pfizer price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.The Pfizer stock prediction results are shown below and presented as a graph, table and text information. Pfizer stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pfizer analysts is $ 40.1 . Today 200 Day Moving Average is the resistance level ( 37.34 $).Dr. Fauci has implied that the omicron variant may not be as severe as feared. Vaccine stocks have taken a hit as a result. Dr. Fauci's recent comments are good news for public health but bad news for vaccine stocks Good news for public hea...Their CRSP share price targets range from $42.00 to $110.00. On average, they anticipate the company's share price to reach $69.88 in the next year. This suggests a possible upside of 2.9% from the stock's current price. View analysts price targets for CRSP or view top-rated stocks among Wall Street analysts.Next reporting date: February 6, 2024: EPS forecast (this quarter) $2.78: Annual revenue (last year) $28.5B: Annual profit (last year) $6.2B: Net profit marginPfizer Inc. analyst ratings, historical stock prices, earnings estimates & actuals. PFE updated stock price target summary.

PG Stock 12 Months Forecast. $164.24. (8.72% Upside) Based on 19 Wall Street analysts offering 12 month price targets for Procter & Gamble in the last 3 months. The average price target is $164.24 with a high forecast of $179.00 and a low forecast of $139.00. The average price target represents a 8.72% change from the last price of $151.07.Pfizer stock forecast for this year. Pfizer stock forecast for Dec 2023. Estimated Average Forecasted Pfizer Price: 32.95. Positive monthly dynamics of the instrument is expected with 10.203% volatility is expected.Dec 2, 2023 · Pfizer Inc Fair Value Forecast for 2023 - 2025 - 2030 In the last three years, Pfizer Inc's Price has grown by 123.05%, from $34.34 to $76.59. 19 analysts predict Pfizer Inc's Fair Value will decrease by 17.02% in the next year, reaching $63.55. By 2030, professionals predict that Pfizer Inc's Fair Value will decrease by 50.76%, to $37.71. Pfizer, Inc. (PFE.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Pfizer, Inc. | Nyse: PFE | NyseInstagram:https://instagram. best penny shares appdonnelley financialinteractive brokers mutual fundsnasdaq acad Target values for the price of one Pfizer share for Aug 2024. The weighted average target price per Pfizer share in Aug 2024 is: 35.59. In Aug, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 7.887% volatility is expected. Pessimistic target level: 33.67. Optimistic target level: 36.55.Oct 16, 2023 · Listen. 4:34. Pfizer Inc. ’s announcement that it will cut $9 billion from annual sales guidance due to declining demand for Covid shots and pills was met with relief by investors eager to ... philadelphia financial advisor1921 morgan silver dollars value Target values for the price of one Paysafe share for Jun 2025. The weighted average target price per Paysafe share in Jun 2025 is: 15.29. In Jun, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 8.917% volatility is expected. Pessimistic target level: 14.50. Optimistic target level: 15.92.17 equities research analysts have issued 12 month price targets for Pfizer's stock. Their PFE share price targets range from $33.00 to $75.00. On average, they predict the company's share price to reach $42.50 in the next twelve months. This suggests a possible upside of 45.4% from the stock's current price. s p rating Nov 30, 2023 · Pfizer Stock Forecast 2025-2029. These five years would bring an increase: Pfizer price would move from $33.59 to $52.68, which is up 57%. Pfizer will start 2025 at $33.59, then soar to $34.73 within the first six months of the year and finish 2025 at $35.98. In 2025, JNJ is forecast to generate $27,154,102,834 in earnings, with the lowest earnings forecast at $26,648,574,323 and the highest earnings forecast at $27,563,340,199. ... Street analysts that have issued a 1 year JNJ price target, the average JNJ price target is $165.82, with the highest JNJ stock price forecast at $215.00 and the lowest JNJ stock …Pfizer (PFE-5.12%) has been an underachiever. Sure, the company launched a successful COVID-19 vaccine and has built a large pipeline. However, its shares have lagged well behind the market for years.